Abstract
HTLV-1 virus infection and the molecular mechanisms associated with lymphomagenesis inATLL are scarce. Although it takes six decades of latent viral infection until the development ofT lymphoproliferative neoplasia, there is no biological marker that can be used in the clinical andlaboratory monitoring of asymptomatic carriers of HTLV-1. Carriers who acquired HTLV-1 viathe vertical route …